TSE:MDA

MDA Space Ltd. (MDA.TO)

56.02
-3.09 (5.23%)
as of Jun 22, 2026, 8:00:00 pm Market Open.
216 watching
0
Investor Insights
star iconJun 23, 2026, 12:00 am

This summary was created by AI, based on 51 opinions in the last 12 months.

MDA Space Ltd. (MDA-T) has generated mixed reviews among experts, with several highlighting its strong growth potential driven by ongoing demand in the space economy. Analysts note the company's effort to capitalize on the defense sector and the burgeoning niche of low-earth orbit satellites, citing a significant backlog of approximately $4.4 billion. However, concerns exist regarding its high capital intensity and the competitive landscape, particularly with the emergence of SpaceX. The stock's current valuation has sparked debate, with assessments ranging from reasonable to concerningly high, particularly following the loss of a major contract with EchoStar. Despite these challenges, many experts see long-term opportunities, particularly with anticipated government spending in defense and international contracts that could bolster MDA's future growth.

consensus icon
Consensus
Buy
valuation icon
Valuation
Fair Value
review icon
Similar
Airbus, EADSY
TOP PICK

Makes satellites. Leading space tech company, positioned to capitalize on expanding global space economy. Defense plus next-gen telecom satellite applications. Aurora satellite has competitive edge with cost-efficiency and high production volume. Large order backlog. 

Q4 reports next week, and he expects good results and steady stream of new contract announcements. No dividend.

(Analysts’ price target is $47.06)
BUY

A great play on higher defence spending. Canadian defence stocks are rare. But the chart is rocky. Likes it. An obvious choice in defence.

WEAK BUY

Nice run on defense announcements. Pure play on growth in space. Loss of EchoStar contract put question marks on its backlog. It's 31% in the US, so what happens if CUSMA doesn't end well?

He models 14% EPS growth, trading ~21x PE. Given defense spending, not a bad buy here.

premiumPremium content

It's a Monthly Gems opinion which is available only for Stockchase Premium

Curated by Allan Tong since 2019.
99+ opinions with 4.15 rating.

TOP PICK

Losing the $1.8-billion contract with American telecom EchoStar set them back, but MDA still reported Q3 revenue growth of 45% year-over-year while gross profits rose 43% in that period. Nearly 75% of MDA's business comes from satellites, and this segment gained 69% in this span. More than half of MDA's $4.4-billion pipeline is in satellites. MDA plays into the prevailing theme of defence, while its cash flow is good. Already in 2026, the stock has run up over 50%, but there's still room to run with the street targeting $46.06, about $8 higher than presently. Stockchaser Trevor Rose likes it for its moat.

BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

Yes, we think MDA offers good potential and it also has scarcity value and is in a sector with high barriers to entry.
Unlock Premium - Try 5i Free

HOLD

A small cap, and small caps are coming into vogue right now. Up 35% in the last year. Robotics, satellite systems, and geo-intelligence technology to the space industry. Elon Musk wanting to put up more satellites falls into this company's bailiwick. Aerospace is having its time to shine. Worth owning.

He owns HEI and CAE instead.

BUY

Lots of volatility. Part of the Golden Dome -- no $$ amount associated with that, but that they're part of it is a good endorsement. Needs to diversify its client base. Business is doing well, generates cashflow. A mission-critical company in Canada, with opportunities in Europe. Exposed to the right themes of defense and national security. A good hold for the next several years.

PAST TOP PICK
(A Top Pick Jul 09/25, Down 24%)

(Note the short-ish timeframe.)  Unfortunate news with losing EchoStar contract, and worry on Globalstar contract (this one has abated). Continues to add new projects and new contracts.

He got stopped out on the initial drop. Waiting for consolidation after tax-loss selling, and it's approaching a point for re-entry.

WAIT

Excitement in the space race again. Price spike fueled by the contract backlog and sector hype. Crash came from timing risk, debt worries, and valuation reality check. Fundamentals remain solid. Next leg depends on almost-flawless execution. Margins are healthy. Long-term setup looks constructive, but has to deliver.

Wait to see execution on backlog before considering a position.

DON'T BUY

Technically failed after it hit $40, so he moved to the sidelines. Other things to do right now.

PAST TOP PICK
(A Top Pick Jul 09/25, Down 35%)

(Note the short timeframe.)  Bad luck this year. When it lost that EchoStar contract it broke technical levels, and he got stopped out. Still really likes the business, which will be significantly bigger in 10 years. He watches it very closely for a chance to get back in.

BUY

Their last numbers beat the street. There have been delays with a project, but overall MDA will do well. They have a strong backlog. Trades at 13x PE 2026, not expensive. It helps that around the world, countries are thinking of defense. MDA executes well. If Global Star overcomes its delay, MDA could grow their top and bottom lines.

RISKY

MDA got caught up in the speculative frenzy over and shares have returned to Earth. But at this valuation it looks interesting. Doesn't know the company fundamentals, and doesn't follow it. Will be volatile when the space sector gets hot and not.

DON'T BUY

A struggle. He owned his twice this year. Hard to own. Very volatile this year. The current collapse concerns him. It took Feb-June to bottom out, so it may take several months for this to bottom out. The chart shows a Triple Waterfall, so a third down leg could lie ahead. He wouldn't return to this until it bottoms out and shows relative strength.

PARTIAL BUY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

EPS of 35c beat estimates of 34c; revenue of $409.8M beat estimates of $403.2M. EBITDA of $82.8M beat estimates by 6%. Guidance was affirmed. EBITDA margin rose 20.2%, 0.9 points above estimates. Backlog was $4.39B, lower than estimates ($5.13B). Revenue rose 45% from last year. This was a good quarter and the stock has responded, but investors are still concerned about potential contract losses. We would be fine buying a partial position today. 
Unlock Premium - Try 5i Free  

Showing 16 to 30 of 90 entries